| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3191549 | Annals of Allergy, Asthma & Immunology | 2013 | 6 Pages |
Abstract
The decision points of sIgE obtained in different age groups may help to determine the likelihood of clinical reactivity more precisely. The results suggest that sIgE levels and STAT6 gene variants may be important determinants to predict longer persistence of CMA.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
S. Tolga MD, Betul MD, Umit M. MD, Esra PhD, Ayfer MD, Selin MD, Erdem PhD, Omer MD, Cansin MD,